Whole-Body Vibration Exercise in Cancer

  • Patrícia Lopes-SouzaEmail author
  • Danúbia da Cunha de Sá-Caputo
  • Redha Taiar
  • Mario Bernardo-Filho


Cancer is a generic term for a large group of malignant diseases that can affect any part of the body. Although the treatment of cancer is constantly improving survival of the individual, cancer and cancer treatment often result in psychological and physiological sequelae and side effects that impact on the functional ability and the performance to do essential daily activities. The adverse effects of cancer treatments can disturb every part of the body with manifestations such as gastrointestinal problems, vascular complications, bone loss, cancer-related fatigue, neurological effects, cancer-related cognitive impairment, and muscle and cardiorespiratory function, urinary function, and skin function impairment leading to other psychological and physical impairments. Exercise program can be considered an intervention capable of influencing multiple systems and psychophysiological pathways simultaneously and might be useful to compensate adverse effects and also to enhance quality of life. Exercise improves muscle atrophy and weakness, bone mass, fatigue, immune function, insomnia, anxiety, cognitive decline, and quality of life, among others. Works have shown the whole-body vibration exercise (WBV) benefits in the rehabilitation programs of patients with chronic diseases. There are an increasing number of investigations on the effects of WBV on functional exercise capacity reduction, fatigue, weakness, urinary incontinence, bone loss, and peripheral neuropathy in cancer survivors. The relevance of WBV to the management of cancer survivors will be shown in this chapter.


Cancer Exercise Whole-body vibration Fatigue Weakness Peripheral neuropathy Rehabilitation 



The authors thank the following Brazilian agencies for the financial support: Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Universidade do Estado do Rio de Janeiro (UERJ).


  1. 1.
    World Health Organization (WHO). WHO list of priority medical devices for cancer management [Internet]. Accessed 19 Jul 2019.
  2. 2.
    World Health Organization (WHO). Latest global cancer data: cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018 [Internet]. Accessed 19 Jul 2019.
  3. 3.
    Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.PubMedGoogle Scholar
  4. 4.
    Charalambous A. Cancer-related fatigue and sleep deficiency in cancer care continuum: concepts, assessment, clusters, and management. Support Care Cancer. 2019;27:2747–53.PubMedGoogle Scholar
  5. 5.
    Kilari D, Soto-Perez-de-Celis E, Gupta S, Alibhai SMH, Presley CJ, Wildes TM, et al. Designing exercise clinical trials for older adults with cancer: recommendations from 2015: Cancer and Aging Research Group NCI U13 Meeting. J Geriatr Oncol. 2016;7(4):293–304.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Weaver K, Forsythe L, Reeve B, Alfano C, Rodriguez J, Sabatino S, et al. Mental and physical health-related quality of life among US cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2012;21(11):1–17.Google Scholar
  7. 7.
    Cleeland CS, Allen JD, Roberts SA, Brell JM, Giralt SA, Khakoo AY, et al. Reducing the toxicity of cancer therapy. Nat Publ Gr. 2012;9(8):471–8.Google Scholar
  8. 8.
    Hsu H, Tsai S, Wu S, Jeang S, Ho M. Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer. Support Care Cancer. 2017;25:3457–64.PubMedGoogle Scholar
  9. 9.
    Poh K, Lin P, Uth J, Quist M, Klepin H, Mustian K. Exercise for managing cancer- and treatment-related side effects in older adults. J Geriatr Oncol. 2018;9(4):405–10.Google Scholar
  10. 10.
    Mustian KM, Sprod LK, Palesh OG, Peppone LJ, Janelsins MC, Mohile SG, et al. Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep. 2009;8(6):325–30.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Irwin ML, Alvarez-reeves M, Cadmus L, Mierzejewski E, Mayne ST, Yu H, et al. Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity. 2009;17:1534–41.PubMedGoogle Scholar
  12. 12.
    Sá-Caputo DC, Paineiras-Domingos LL, Oliveira R, Neves MFT, Brandão A, Marin PJ, et al. Acute effects of whole-body vibration on the pain level, flexibility, and cardiovascular responses in individuals with metabolic syndrome. Dose-Response. 2018;16(4):1–9.Google Scholar
  13. 13.
    Furness T, Bate N, Welsh L, Naughton G, Lorenzen C. Efficacy of a whole-body vibration intervention to effect exercise tolerance and functional performance of the lower limbs of people with chronic obstructive pulmonary disease. BMC Pulm Med. 2012;12:71.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Prioreschi A, Makda MA, Tikly M, McVeigh JA. In patients with established RA, positive effects of a randomised three month WBV therapy intervention on functional ability, bone mineral density and fatigue are sustained for up to six months. PLoS One. 2016;11(4):1–16.Google Scholar
  15. 15.
    Pahl A, Wehrle A, Kneis S, Gollhofer A, Bertz H. Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study. BMC Cancer. 2018;18(1):1–12.Google Scholar
  16. 16.
    Crevenna R, Cenik F, Margreiter M, Marhold M, Sedghi Komanadj T, Keilani M. Whole body vibration therapy on a treatment bed as additional means to treat postprostatectomy urinary incontinence. Wien Med Wochenschr. 2017;167(5–6):139–41.PubMedGoogle Scholar
  17. 17.
    Baker MK, Peddle-mcintyre CJ, Galvão DA, Hunt C, Spry N, Newton RU. Whole body vibration exposure on markers of bone turnover, body composition, and physical functioning in breast cancer patients receiving aromatase inhibitor therapy: a randomized controlled trial. Integr Cancer Ther. 2018;17(3):163–7.Google Scholar
  18. 18.
    Salhi B, Haenebalcke C, Perez-Bogerd S, Nguyen MD, Ninane V, Malfait TLA, et al. Rehabilitation in patients with radically treated respiratory cancer: a randomised controlled trial comparing two training modalities. Lung Cancer. 2015;89(2):167–74.PubMedGoogle Scholar
  19. 19.
    Van Ruymbeke B, Boone J, Coorevits P, Vanderstraeten G, Bourgois J. Whole-body vibration in breast cancer survivors. Int J Rehabil Res. 2014;37(4):371–4.PubMedGoogle Scholar
  20. 20.
    Verhulst ALJ, Savelberg HHCM, Vreugdenhil G, Mischi M, Schep G. Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy. Oncol Rev. 2015;9(1):1–6.Google Scholar
  21. 21.
    Bemben D, Stark C, Taiar R, Bernardo-Filho M. Relevance of whole-body vibration exercises on muscle strength/power and bone of elderly individuals. Dose-Response. 2018;16(4):1–7.Google Scholar
  22. 22.
    Wei N, Pang MYC, Ng SSM, Ng GYF. Optimal frequency/time combination of whole body vibration training for developing physical performance of people with sarcopenia: a randomized controlled trial. Clin Rehabil. 2017;31(10):1313–21.PubMedGoogle Scholar
  23. 23.
    Totosy de Zepetnek JO, Giangregorio LM, Craven BC. Whole-body vibration as potential intervention for people with low bone mineral density and osteoporosis: a review. J Rehabil Res Dev. 2009;46(4):529–42.PubMedGoogle Scholar
  24. 24.
    Wallmann HW, Evans BL, Paicely AM, Hyman AA, Goss GK, Bell DL. The effects of whole body vibration on vertical jump, power, balance, and agility in untrained adults. Int J Sports Phys Ther. 2019;14(1):55–64.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Figueroa A, Jaime SJ, Alvarez-Alvarado S. Whole-body vibration as a potential countermeasure for dynapenia and arterial stiffness. Integr Med Res. 2016;5(3):204–11.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Corum M, Basoglu C, Yakal S, Sahinkaya T, Aksoy C. Effects of whole body vibration training on isokinetic muscular performance, pain, function, and quality of life in female patients with patellofemoral pain: a randomized controlled trial. J Musculoskelet Neuronal Interact. 2018;18(4):473–84.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Schönsteiner SS, Mißbach HB, Benner A, Mack S, Hamel T, Orth M, et al. A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. Exp Hematol Oncol. 2017;6(5):1–11.Google Scholar
  28. 28.
    Hirsch JK, Sirois FM. Hope and fatigue in chronic illness: the role of perceived stress. J Health Psychol. 2015;25:1–6.Google Scholar
  29. 29.
    Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528–38.PubMedGoogle Scholar
  30. 30.
    Ebede CC. Cancer-related fatigue in cancer survivorship. Med Clin NA. 2017;101(6):1085–97.Google Scholar
  31. 31.
    Berger AM, Mooney K, Alvarez-perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2015;13(8):1012–39.Google Scholar
  32. 32.
    Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16:791–801.PubMedGoogle Scholar
  33. 33.
    Goedendorp MM, Gielissen MFM. Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J Pain Symptom Manag. 2013;45(2):213–22.Google Scholar
  34. 34.
    Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults (review). Cochrane Database Syst Rev. 2012;11:CD006145.PubMedGoogle Scholar
  35. 35.
    Bower JE. Cancer-related fatigue –mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Yang S, Chu S, Gao Y, Ai Q, Liu Y, Li X, et al. A narrative review of Cancer-Related Fatigue (CRF) and its possible pathogenesis. Cell. 2019;8(738):1–19.Google Scholar
  37. 37.
    Neefjes ECW, van den Hurk RM, Blauwhoff-Buskermolen S, van der Vorst MJDL, Becker-Commissaris A, de van der Schueren MAE, et al. Muscle mass as a target to reduce fatigue in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2017;8(4):623–9.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology Clinical Practice Guideline adaptation. J Clin Oncol. 2014;32(17):1840–50.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Alentorn-Geli E, Padilla J, Moras G, Haro C, Fernández-Solà J. Six weeks of whole-body vibration exercise improves pain and fatigue in women with fibromyalgia. J Altern Complement Med. 2008;14(8):975–81.PubMedGoogle Scholar
  40. 40.
    Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P. Muscle dysfunction in cancer patients. Ann Oncol. 2014;25(11):947–58.PubMedGoogle Scholar
  41. 41.
    Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95.PubMedGoogle Scholar
  42. 42.
    Milgrom DP, Lad NL, Koniaris LG, Zimmers TA. Bone pain and muscle weakness in cancer patients. Curr Osteoporos Rep. 2017;15:76–87.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Ryan AM, Power DG, Daly L, Cushen SJ, Ní E. Conference on ‘Nutrition at key life stages: new findings, new approaches’ Julie Wallace lecture Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later Proceedings of the Nutrition Society Procee. Proc Nutr Soc. 2016;75:199–211.PubMedGoogle Scholar
  44. 44.
    Aversa Z, Costelli P, Muscaritoli M. Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol. 2017;9(5):369–82.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K, Aoyagi T, et al. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17–29.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2012;10(2):80–9.Google Scholar
  48. 48.
    Collins J, Noble S, Chester J, Coles B, Byrne A. The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open. 2014;2:4(1).Google Scholar
  49. 49.
    Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40.PubMedGoogle Scholar
  50. 50.
    Wu C, Chang M, Lyadov VK, Liang P, Chen C, Shih TT, et al. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer. Clin Nutr. 2019;38(2):862–9.PubMedGoogle Scholar
  51. 51.
    Kuwada K, Kuroda S, Kikuchi S, Yoshida R, Nishizaki M, Kagawa M, et al. Clinical impact of sarcopenia on gastric cancer evaluation of sarcopenia. Anticancer Res. 2019;39(5):2241–9.PubMedGoogle Scholar
  52. 52.
    Harada K, Ida S, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2015:1–7.Google Scholar
  53. 53.
    Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22:2663–8.PubMedGoogle Scholar
  54. 54.
    Rutten IJG, Van Dijk DPJ, Kruitwagen RFPM, Beets-tan RGH, Olde SWM, Van Gorp T. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016;7(March):458–66.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Aleixo GFP, Nyrop GRWKA, Shachar HBMSS. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review. Breast Cancer Res Treat. 2019;177(3):569–79.PubMedGoogle Scholar
  56. 56.
    Peterson SJ, Mozer M. Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30–9.PubMedGoogle Scholar
  57. 57.
    Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748–59.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A, et al. Physical activity and exercise as countermeasures to physical frailty and sarcopenia. Aging Clin Exp Res. 2017;29(1):35–42.PubMedGoogle Scholar
  59. 59.
    Yamamoto K, Nagatsuma Y, Fukuda Y. Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer. 2017;20(5):913–8.PubMedGoogle Scholar
  60. 60.
    Adams SC, Segal RJ, Mckenzie DC, Vallerand JR, Morielli AR, Mackey JR, et al. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Res Treat. 2016;158(3):497–507.PubMedGoogle Scholar
  61. 61.
    Dawson JK, Dorff TB, Schroeder ET, Lane CJ, Gross ME, Dieli-conwright CM. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial. BMC Cancer. 2018;18(368):1–15.Google Scholar
  62. 62.
    Rodriguez-Miguelez P, Fernandez-Gonzalo R, Collado P, Almar M, Martinez-Florez S, de Paz J, González-Gallego JCM. Whole-body vibration improves the anti-inflammatory status in elderly subjects through toll-like receptor 2 and 4 signaling pathways. Mech Ageing Dev. 2015;150:12–9.PubMedGoogle Scholar
  63. 63.
    Osawa Y, Oguma Y, Ishii N. The effects of whole-body vibration on muscle strength and power: a meta-analysis. J Musculoskelet Neuronal Interact [Internet]. 2013;13(3):380–90.Google Scholar
  64. 64.
    Lai CC, Tu YK, Wang TG, Huang YT, Chien KL. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47(3):367–73.PubMedGoogle Scholar
  65. 65.
    Rustler V, Prokop A, Baumann FT, Streckmann F, Bloch W. Whole-body vibration training designed to improve functional impairments after pediatric inpatient anticancer therapy: a pilot study. Pediatr Phys Ther. 2018;30(4):341–9.PubMedGoogle Scholar
  66. 66.
    Pfeilschifter J, Diel I. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol. 2000;18(7):1570–93.PubMedGoogle Scholar
  67. 67.
    Drake M. Osteoporosis and Cancer. Curr Osteoporos Rep. 2014;11(3):163–70.Google Scholar
  68. 68.
    Kim S, Cho Y, Kim S, Han M. Changes in bone mineral density in women with breast cancer a prospective cohort. Cancer Nurs. 2018:1–9.Google Scholar
  69. 69.
    Kimura T, Koike Y, Aikawa K, Kimura S, Mori K, Sasaki H, et al. Short-term impact of androgen deprivation therapy on bone strength in castration-sensitive prostate cancer. Int J Urol. 2019;26(10):980–4.PubMedGoogle Scholar
  70. 70.
    Miyazawa Y, Sekine Y, Syuto T, Nomura M. Effect of androgen-deprivation therapy on bone mineral. In Vivo (Brooklyn). 2018;32(2):409–12.Google Scholar
  71. 71.
    Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, et al. Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors. Ann Oncol. 2019;30(6):908–20.PubMedGoogle Scholar
  72. 72.
    Almstedt HC, Grote S, Korte JR, Perez S, Shoepe TC, Strand S, et al. Combined aerobic and resistance training improves bone health of female cancer survivors. Bone Rep [Internet]. 2016;5:274–9.Google Scholar
  73. 73.
    Saarto T, Sievänen H, Kellokumpu-Lehtinen P, Nikander R, Vehmanen L, Huovinen R, Kautiainen H, Järvenpää S, et al. Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial. Osteoporos Int. 2012;23:1601–12.PubMedGoogle Scholar
  74. 74.
    Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, et al. A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial. BMC Cancer. 2017;17(822):1–15.Google Scholar
  75. 75.
    Marín-Cascales E, Alcaraz P, Ramos-Campo DJ, Martinez-Rodriguez A, Chung L, Rubio-Arias J. Whole-body vibration training and bone health in postmenopausal women. Medicine (Baltimore). 2018;97(34):e11918.Google Scholar
  76. 76.
    Mogil RJ, Kaste SC, Ferry RJ Jr, Hudson MM, Mulrooney DA, Howell CR, et al. Effect of low-magnitude, high-frequency mechanical stimulation on BMD among young childhood cancer survivors: a randomized clinical trial. JAMA Oncol. 2016;2(7):908–14.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Parsons BA, Evans S, Wright MP. Prostate cancer and urinary incontinence. Maturitas. 2009;63:323–8.PubMedGoogle Scholar
  78. 78.
    Karlsson L, Asplund D, Rosenberg J, Hospital B, Hospital H. Urinary dysfunction in patients with rectal cancer: a prospective cohort study. Color Dis. 2019.Google Scholar
  79. 79.
    Segal AS, John G, Sammel M, Andy U, Chu C, Arya LA, et al. Urinary incontinence and other pelvic floor disorders after radiation therapy in endometrial cancer survivors. Maturitas [Internet]. 2017;105:83–8.Google Scholar
  80. 80.
    Fernández R, García-Hermoso A, Solera-Martínez M, Correa M, Morales A, Martínez-Vizcaíno V. Improvement of continence rate with pelvic floor muscle training post-prostatectomy: a meta-analysis of randomized controlled trials. Urol Int. 2015;94(2):125–32.PubMedGoogle Scholar
  81. 81.
    Hodges P, Stafford R, Coughlin GD, Kasza J, Ashton-miller J, Cameron AP, et al. Efficacy of a personalised pelvic floor muscle training programme on urinary incontinence after radical prostatectomy (MaTchUP): protocol for a randomised controlled trial. BMJ Open. 2019;9(5):e028288.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Gresty H, Walters U, Rashid T. Post-prostatectomy incontinence: multimodal modern-day management. Br J Community Nurs. 2019;24(4):154–9.PubMedGoogle Scholar
  83. 83.
    Ramaseshan AS, Felton J, Roque D, Rao G, Shipper AG, Sanses TVD. Pelvic floor disorders in women with gynecologic malignancies: a systematic review. Int Urogynecol J. 2018;29(4):459–76.Google Scholar
  84. 84.
    Rutledge TL, Rogers R, Lee S, Muller CY. A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors. Gynecol Oncol. 2014;132(1):154–8.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Pan L, Lin M, Pang S, Wang J, Shih W. Improvement of urinary incontinence, life impact, and depression and anxiety with modified pelvic floor muscle training after radical prostatectomy. Am J Mens Health. 2019;13(3).Google Scholar
  86. 86.
    Crevenna R, Cenik F, Margreiter M, Marhold M, Sedghi T. Case report: whole body vibration therapy on a treatment bed as additional means to treat postprostatectomy urinary incontinence. Wien Med Wochenschr. 2016:1–3.Google Scholar
  87. 87.
    Tantawy SA, Elgohary HMI, Abdelbasset WK, Kamel DM. Effect of 4 weeks of whole-body vibration training in treating stress urinary incontinence after prostate cancer surgery: a randomised controlled trial. Physiotherapy. 2018;105(3):338–45.PubMedGoogle Scholar
  88. 88.
    Guedes-Aguiar EO, de Sá-Caputo DDC, Moreira-Marconi E, de Macêdo Uchôa SM, de Barros PZ, Valentin EK, Bergmann A, Taiar R, Bernardo-Filho M. Effect of whole-body vibration exercise in the pelvic floor muscles of healthy and unhealthy individuals: a narrative review. Transl Androl Urol. 2019;8(4):395–404.PubMedPubMedCentralGoogle Scholar
  89. 89.
    Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2017;140(1):176–83.Google Scholar
  90. 90.
    Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Support Care Cancer. 2019;27(10):3729–37.PubMedGoogle Scholar
  91. 91.
    Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, Macleod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–70.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Ajewole VB, Cox JE, Swan JT, Chikermane SG, Lamoth B, Iso T, et al. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study. Support Care Cancer. 2020;28(4):1901–12.PubMedGoogle Scholar
  93. 93.
    Eldridge S, Guo L, Iii JH. A comparative review of chemotherapy-induced peripheral neuropathy in in vivo and in vitro models. Toxicol Pathol. 2020;48(1):190–201.PubMedGoogle Scholar
  94. 94.
    Kleckner I, Kamen C, Gewandter J, Mohile N, Heckler C, Culakova E, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018;26(4):1019–28.PubMedGoogle Scholar
  95. 95.
    Hammond EA, Pitz M, Shay B. Neuropathic pain in taxane-induced peripheral neuropathy: evidence for exercise in treatment. Neurorehabil Neural Repair. 2019.Google Scholar
  96. 96.
    Duregon F, Vendramin B, Bullo V, Gobbo S, Cugusi L, Di A, et al. Critical reviews in oncology/hematology effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review. Crit Rev Oncol/Hematol. 2017;121:90–100.Google Scholar
  97. 97.
    Lee K. Effects of whole-body vibration therapy on perception thresholds of type 2 diabetic patients with peripheral neuropathy: a randomized controlled trial. J Phys Ther Sci. 2017;29:1684–8.PubMedPubMedCentralGoogle Scholar
  98. 98.
    Streckmann F, Lehmann HC, Balke M, Schenk A, Oberste M, Heller A, et al. Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy – a randomized controlled pilot trial. Support Care Cancer. 2018;27(7):2471–8.PubMedGoogle Scholar
  99. 99.
    Lopes-Souza P, Dionello CF, Sá-Caputo DC, Bergmann A, Furness T, Bernardo-filho M. Whole body vibration exercise in the management of cancer therapy-related morbidities: a systematic review. Drug Discov Ther. 2018;12(4):239–47.PubMedGoogle Scholar
  100. 100.
    Lai C, Tseng S, Chen C, Liao W, Wang C, Lee M, et al. Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women: a randomized controlled trial. Clin Interv Aging. 2013;8:1603–9.PubMedPubMedCentralGoogle Scholar
  101. 101.
    Marín-cascales E. Effects of 24 weeks of whole body vibration versus multicomponent training on muscle strength and body composition in postmenopausal women: a randomized controlled trial. Rejuvenation Res. 2016;20(3):193–201.Google Scholar
  102. 102.
    Rustler V, Däggelmann J, Streckmann F, Bloch W, Baumann F. Whole-body vibration in children with disabilities demonstrates therapeutic potentials for pediatric cancer populations: a systematic review. Support Care Cancer. 2019;27:395–406.PubMedGoogle Scholar
  103. 103.
    Streckmann F, Balke M, Lehmann HC, Rustler V, Koliamitra C, Elter T, et al. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies – STOP. BMC Cancer. 2018;18(62):1–10.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Patrícia Lopes-Souza
    • 1
    • 2
    • 3
    • 4
    Email author
  • Danúbia da Cunha de Sá-Caputo
    • 2
    • 5
  • Redha Taiar
    • 6
  • Mario Bernardo-Filho
    • 2
  1. 1.Programa de Pós-graduação em Ciências Médicas, Faculdade de Ciências MédicasUniversidade do Estado do Rio de JaneiroRio de JaneiroBrazil
  2. 2.Departamento de Biofísica e Biometria, Laboratório de Vibrações Mecânicas e Práticas Integrativas, Instituto de Biologia Roberto Alcantara Gomes e Policlínica Piquet CarneiroUniversidade do Estado do Rio de JaneiroRio de JaneiroBrazil
  3. 3.Divisão de Fisioterapia, Policlínica Piquet CarneiroUniversidade do Estado do Rio de JaneiroRio de JaneiroBrazil
  4. 4.Departamento de Fisioterapia do Hospital do Câncer IIInstituto Nacional de Câncer José Alencar Gomes da Silva (INCA)Rio de JaneiroBrazil
  5. 5.Curso de Fisioterapia, Faculdade Bezerra de AraújoRio de JaneiroBrazil
  6. 6.Department of Physical ExerciseUniversité Reims Champagne-ArdennesReimsFrance

Personalised recommendations